The committee will discuss the proposed Emergency Use Authorization (EUA) of the Janssen Biotech Inc. COVID-19 Vaccine for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years and older.

The docket number is FDA-2021-N-0173. Search www.regulations.gov for information.

Webcast: https://youtu.be/Qd7mlCD-rEA